Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | July 28, 2022 |
| Target | Axxam |
| Sector | Life Science |
| Buyer(s) | Keensight Capital |
| Sellers(s) |
Bayer
Zambon Company |
| Deal Type | Divestiture |
FILTER BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2000 |
| PE ASSETS | 5.5B EUR |
| Size | Mega |
| Type | Sector Agnostic |
Keensight Capital is a private equity investment firm focused on majority and minority growth capital investments in Western European companies. Keensight makes equity investments in a number of situations including the provision of capital to finance growth, either organically or through acquisitions, or the buying out of existing shareholders. The Firm looks to invest €10 to €600 million and will consider business with up to €400 million in revenue. Keensight Capital was formed in 2000 and is based in Paris.
| Deal Context for Buyer | # |
|---|---|
| Overall | 39 of 54 |
| Sector: Life Science | 6 of 9 |
| Type: Divestiture | 3 of 4 |
| Country: Italy | 2 of 2 |
| Year: 2022 | 6 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-07-22 |
BYG4lab
L'Union, France BYG4lab is a software publisher specializing in medical biology middleware solutions. The Company provides a number of key benefits, including but not limited to: improving workflow management, making instrument integration more efficient, handling mega lab configuration, designing personalized dashboards, maximizing automatic validation, and managing quality control. The Company addresses both Central Lab and Point of Care testing, as well as all disciplines in the field of medical biology – immunochemistry, hematology, molecular, microbiology. BYG4lab was founded in 1982 and is based in L'Union, France. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-10-26 |
Unither Pharmaceuticals
Amiens, France Unither Pharmaceuticals is a developer and manufacturer of pharmaceuticals products. Unither operates six manufacturing sites in France, the United States, and Brazil, and has a dedicated research and development center in Europe. Unither Pharmaceuticals was founded in 1993 and is based in Amiens, France. |
Sell | - |
| Category | Company |
|---|---|
| Founded | 1863 |
| Sector | Life Science |
| Employees | 89,556 |
| Revenue | 46.6B EUR (2024) |
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer was founded in 1863 and is based in Leverkusen, Germany.
| Deal Context for Seller | # |
|---|---|
| Overall | 22 of 24 |
| Sector: Life Science | 7 of 7 |
| Type: Divestiture | 18 of 20 |
| Country: Italy | 1 of 1 |
| Year: 2022 | 4 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-07-14 |
Nebido
Leverkusen, Germany Nebido provides treatment of male hypogonadism (testosterone deficiency) is based in Leverkusen, Germany. |
Sell | €500M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-01-18 |
Blackford Analysis
Edinburgh, United Kingdom Blackford Analysis provides infrastructure and access to a rich clinical application (ClinApp) ecosystem focused on imaging and analytics. Blackford Analysis is based in Edinburgh, United Kingdom. |
Buy | - |
Zambon Company S.p.A. is a multicultural group with close links to its local markets and the international research community. Zambon a pharmaceutical and chemical multinational with a reputation for inventive and innovative thinking, flexibility and customer focus.
| Deal Context for Seller | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science | 2 of 2 |
| Type: Divestiture | 2 of 2 |
| Country: Italy | 1 of 1 |
| Year: 2022 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-07-25 |
Breath Therapeutics
Munich, Germany Breath Therapeutics is a clinical stage biopharmaceutical company specializing in advanced inhaled therapeutics for severe respiratory diseases with a high unmet medical need. |
Buy | €140M |
